angiotensin ii has been researched along with Invasiveness, Neoplasm in 15 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (6.67) | 18.7374 |
| 1990's | 1 (6.67) | 18.2507 |
| 2000's | 10 (66.67) | 29.6817 |
| 2010's | 3 (20.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, JY; Li, Y; Wei, W; Wu, HX; Xu, ZW; Yan, SX; Zhang, Y | 1 |
| Hirose, T; Kaneko, K; Nishiyama, H; Ohba, K; Sasano, H; Suzuki, T; Takahashi, K; Totsune, K | 1 |
| Wang, Q; Wu, G; Zhao, W | 1 |
| Chihara, Y; Denda, A; Fujii, K; Kuniyasu, H; Luo, Y; Ohmori, H; Sasahira, T; Shimomoto, T; Tatsumoto, N | 1 |
| Ino, K; Kajiyama, H; Kikkawa, F; Mizutani, S; Nomura, S; Shibata, K; Suganuma, T; Tsuruoka, N | 1 |
| Ino, K; Kajiyama, H; Kikkawa, F; Mizuno, M; Mizutani, S; Morita, T; Nomura, S; Shibata, K | 1 |
| Ino, K; Kajiyama, H; Kikkawa, F; Mizutani, S; Nagasaka, T; Shibata, K; Suganuma, T | 1 |
| Jin, D; Kondo, K; Miyazaki, M; Muramatsu, M; Okamoto, Y; Takai, S; Tanigawa, N | 1 |
| Aoki, A; Naito, K; Nakamura, K; Shimabukuro, T; Tei, Y; Uchiyama, K | 1 |
| Cazaubon, S; Couraud, PO; Deshayes, F; Nahmias, C | 1 |
| Barker, S; Puddefoot, JR; Tahmasebi, M; Vinson, GP | 1 |
| Barker, S; Puddefoot, JR; Udeozo, UK; Vinson, GP | 1 |
| Göthlin, JH; Kråkenes, J; Tvete, S | 1 |
| Furukawa, H; Hiratsuka, M; Imaoka, S; Ishikawa, O; Kabuto, T; Kameyama, M; Masutani, S; Nakamori, S; Ohigashi, H; Sasaki, Y | 1 |
| Bullock, GR; De Paepe, B; De Potter, CR; Vakaet, LA; Verstraeten, VL | 1 |
1 review(s) available for angiotensin ii and Invasiveness, Neoplasm
| Article | Year |
|---|---|
[Endothelin-1, angiotensin II and cancer].
Topics: Angiogenesis Inhibitors; Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Antineoplastic Agents; Benzimidazoles; Biphenyl Compounds; Clinical Trials as Topic; Endothelin-1; Humans; Neoplasm Invasiveness; Neoplasms; Neovascularization, Pathologic; Receptors, Angiotensin; Receptors, Endothelin; Tetrazoles | 2006 |
14 other study(ies) available for angiotensin ii and Invasiveness, Neoplasm
| Article | Year |
|---|---|
The influence of TNF-α and Ang II on the proliferation, migration and invasion of HepG2 cells by regulating the expression of GRK2.
Topics: Angiotensin II; Antineoplastic Agents; Apoptosis; Cell Line, Tumor; Cell Movement; Cell Proliferation; Flow Cytometry; G-Protein-Coupled Receptor Kinase 2; Gene Knockdown Techniques; Humans; Neoplasm Invasiveness; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2; Receptors, Tumor Necrosis Factor, Type I; RNA, Small Interfering; Tumor Necrosis Factor-alpha | 2017 |
Expression of (pro)renin receptor in breast cancers and its effect on cancercell proliferation.
Topics: Adult; Aged; Angiotensin II; Biomarkers, Tumor; Breast Neoplasms; Cell Line, Tumor; Cell Proliferation; Female; Gene Expression; Humans; Immunohistochemistry; Macrolides; Middle Aged; Mitogen-Activated Protein Kinase 1; Mitogen-Activated Protein Kinase 3; Neoplasm Grading; Neoplasm Invasiveness; Neoplasm Metastasis; Neoplasm Staging; Phosphorylation; Receptors, Cell Surface; Renin; Risk Factors; RNA Interference; Vacuolar Proton-Translocating ATPases | 2014 |
Valsartan inhibits NPC cell line CNE-2 proliferation and invasion and promotes its sensitivity to radiation.
Topics: Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Apoptosis; Blotting, Western; Cell Adhesion; Cell Movement; Cell Proliferation; Cobalt Radioisotopes; Enzyme-Linked Immunosorbent Assay; Flow Cytometry; Gamma Rays; Humans; Nasopharyngeal Neoplasms; Neoplasm Invasiveness; Radiation Tolerance; Real-Time Polymerase Chain Reaction; Receptor, Angiotensin, Type 1; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Tetrazoles; Tumor Cells, Cultured; Valine; Valsartan; Vascular Endothelial Growth Factor A | 2009 |
Diabetes-associated angiotensin activation enhances liver metastasis of colon cancer.
Topics: Angiotensin I; Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Angiotensinogen; Animals; Apoptosis; Cell Line, Tumor; Cell Proliferation; Chymases; Colonic Neoplasms; Diabetes Complications; Diabetes Mellitus; Glucose; Glycated Hemoglobin; HT29 Cells; Humans; Hyperglycemia; Liver Neoplasms; Male; Mice; Mice, Inbred BALB C; Mice, Nude; Neoplasm Invasiveness; Oligoribonucleotides, Antisense; Receptor, Angiotensin, Type 1; Renin; RNA Interference; RNA, Small Interfering | 2012 |
Regulation of aminopeptidase A expression in cervical carcinoma: role of tumor-stromal interaction and vascular endothelial growth factor.
Topics: Angiotensin II; Animals; Cell Division; Cell Line, Tumor; Culture Media, Conditioned; Female; Gene Expression; Glutamyl Aminopeptidase; Humans; Mice; Mice, Nude; Neoplasm Invasiveness; Neoplasm Transplantation; Transfection; Transplantation, Heterologous; Uterine Cervical Dysplasia; Uterine Cervical Neoplasms; Vascular Endothelial Growth Factor A | 2004 |
Activation of invasiveness of cervical carcinoma cells by angiotensin II.
Topics: Angiotensin II; Biomarkers, Tumor; Carcinoma, Squamous Cell; Case-Control Studies; Cell Division; Female; Humans; Immunohistochemistry; Neoplasm Invasiveness; Probability; Receptors, Vascular Endothelial Growth Factor; Reference Values; Sensitivity and Specificity; Tumor Cells, Cultured; Uterine Cervical Neoplasms; Vascular Endothelial Growth Factor A | 2004 |
Functional expression of the angiotensin II type 1 receptor in human ovarian carcinoma cells and its blockade therapy resulting in suppression of tumor invasion, angiogenesis, and peritoneal dissemination.
Topics: Adenocarcinoma; Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Animals; Antigens, CD34; Benzimidazoles; Biphenyl Compounds; Cell Line, Tumor; Dose-Response Relationship, Drug; Female; Humans; Immunohistochemistry; Mice; Mice, Inbred BALB C; Mice, Nude; Neoplasm Invasiveness; Neovascularization, Pathologic; Ovarian Neoplasms; Peritoneum; Receptor, Angiotensin, Type 1; Tetrazoles; Vascular Endothelial Growth Factor A; Xenograft Model Antitumor Assays | 2005 |
Expression of chymase-positive cells in gastric cancer and its correlation with the angiogenesis.
Topics: Adult; Aged; Aged, 80 and over; Angiotensin II; Chymases; Disease Progression; Female; Humans; Lymph Nodes; Lymphatic Metastasis; Male; Mast Cells; Matrix Metalloproteinase 9; Middle Aged; Neoplasm Invasiveness; Neoplasm Staging; Neovascularization, Pathologic; Serine Endopeptidases; Stomach Neoplasms | 2006 |
Angiotensin-II combined intra-arterial chemotherapy for locally advanced bladder cancer: a case series study at a single institution.
Topics: Aged; Aged, 80 and over; Angiotensin II; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Carcinoma, Transitional Cell; Chemotherapy, Adjuvant; Cisplatin; Doxorubicin; Drug Administration Schedule; Female; Humans; Infusions, Intra-Arterial; Male; Middle Aged; Neoadjuvant Therapy; Neoplasm Invasiveness; Neoplasm Staging; Survival Rate; Urinary Bladder Neoplasms | 2006 |
Localisation of renin-angiotensin system (RAS) components in breast.
Topics: Angiotensin II; Angiotensinogen; Breast Neoplasms; Female; Gene Expression Profiling; Humans; Immunohistochemistry; Mammary Glands, Human; Neoplasm Invasiveness; Peptidyl-Dipeptidase A; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2; Renin; Renin-Angiotensin System; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger | 2006 |
The role of angiotensin II in the regulation of breast cancer cell adhesion and invasion.
Topics: Angiotensin II; Breast Neoplasms; Cell Adhesion; Cell Line, Tumor; DNA Primers; Female; Gene Expression Regulation, Neoplastic; Humans; Integrins; Neoplasm Invasiveness; Reverse Transcriptase Polymerase Chain Reaction | 2006 |
The effects of angiotensin on the diagnostics and haemodynamics in renal angiography.
Topics: Angiography; Angiotensin II; Blood Flow Velocity; Contrast Media; Drug Evaluation; Female; Hemodynamics; Humans; Kidney; Kidney Neoplasms; Male; Neoplasm Invasiveness | 1983 |
[Evaluation of intra-arterial infusion chemotherapy and radical pancreatectomy in patients with locally advanced pancreatic cancer].
Topics: Angiotensin II; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Doxorubicin; Drug Administration Schedule; Fluorouracil; Humans; Infusions, Intra-Arterial; Methotrexate; Neoplasm Invasiveness; Pancreatectomy; Pancreatic Neoplasms; Survival Rate | 1993 |
Growth stimulatory angiotensin II type-1 receptor is upregulated in breast hyperplasia and in situ carcinoma but not in invasive carcinoma.
Topics: Angiotensin II; Breast; Breast Neoplasms; Carcinoma in Situ; Cell Division; Dose-Response Relationship, Drug; Female; Fluorescent Antibody Technique; Humans; Hyperplasia; Immunohistochemistry; In Situ Hybridization; Neoplasm Invasiveness; Proliferating Cell Nuclear Antigen; Receptor, Angiotensin, Type 1; Receptors, Angiotensin; RNA, Messenger; Tumor Cells, Cultured; Up-Regulation | 2001 |